All News
Filter News
Found 2,542 articles
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 17, 2020.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Moderna Announces Award from U.S. Government Agency BARDA for up to $483 Million to Accelerate Development of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
4/16/2020
Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced an agreement for a commitment of up to $483 million from the Biomedical Advanced Research and Development Authority (BARDA),
-
Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response
4/15/2020
Deal is part of Ginkgo's $25 million commitment to make its biological discovery and production services available to firms working on diagnostics, treatments, and vaccines in response to COVID-19
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 14, 2020.
-
It’s likely that more companies and universities will add additional assets as time goes on.
-
Moderna's mRNA Zika vaccine data is becoming helpful in the development of the COVID-19 vaccine. The company is using the elements to faster the process of producing the vaccine.
-
Life Science Cares Announces Six New Grants
4/14/2020
Today Life Science Cares announced a second round of grants under the organization’s COVID-19 Response Fund, contributing an additional $270,000 to six nonprofit partners.
-
Moderna Highlights Opportunity of mRNA Vaccines at its First Vaccines Day
4/14/2020
Vaccines create significant value for healthcare systems by preventing infectious disease; despite this, the vast majority of viruses do not have commercial vaccines available, representing a large opportunity
-
China’s CanSino Biologics is advancing its COVID-19 vaccine candidate into Phase II, putting the company ahead of others in the race against the novel coronavirus.
-
As COVID-19 has swept across the world, companies have had to make significant adjustments to the way business is conducted in a global economy. It has impacted all types of operations, including clinical trials.
-
Moderna Announces that Its 2020 Annual Meeting of Stockholders Will be Held in Virtual Format
4/10/2020
Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that, due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic,
-
Pfizer Advances BioNTech COVID-19 Program and Plans Clinical Trials for Potential Treatments
4/9/2020
Pfizer and BioNTech updated their development program, with plans to launch clinical trials in the U.S. and Europe across multiple sites by the end of April. -
Signals Analytics Launches COVID-19 Playbook Analytics Platform to Accelerate Vaccine and Drug De...
4/9/2020
If you’re having trouble keeping up with multiple industry programs aimed at COVID-19, you’re not alone. But, there is a new solution that can help you see the proverbial forest from the trees – Signals Analytics COVID-19 Playbook. -
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.
-
Moderna to Present at 19th Annual Needham Healthcare Conference
4/8/2020
Moderna to Present at 19 th Annual Needham Healthcare Conference
-
While the world is working to slow the COVID-19 pandemic by social isolation and quarantine, numerous companies globally are working to develop a vaccine against the virus.
-
Biotechs Working Closely & Feverishly With CDC for COVID-19 Vaccine Development
4/7/2020
Many companies searching for an effective therapy or vaccine for the present world health crisis are focusing on creating a vaccine from the immune system.
-
FDA Accelerates Development of Novel Therapies for COVID-19
4/7/2020
The U.S. Food and Drug Administration has taken an all-hands-on-deck approach across public, academic and private sectors to combat the COVID-19 pandemic. The new program is designed to expedite the development of potentially safe and effective life-saving treatm
-
Moderna to Host Virtual Vaccines Day on April 14, 2020
4/7/2020
Moderna, Inc. announced that it will host its virtual Vaccines Day for analysts and investors at 8:00 a.m. ET on Tuesday, April 14.